Target intelligence / Profile preview

ASH1L intronic transcript 1 (ASH1L-IT1)

Target
ASH1L-IT1
Molecular classification
long non-coding RNA, not enzyme, not receptor, not transporter
01

Overview

ASH1L intronic transcript 1 (ASH1L-IT1) is a long non-coding RNA arising from an intronic region of the *ASH1L* gene. Unlike the canonical protein-coding ASH1L, which encodes a histone methyltransferase involved in chromatin modification, development, and diverse human diseases, little is concretely established regarding the biological function, disease associations, or therapeutic targetability of ASH1L-IT1. The term is often confused with the protein-coding ASH1L, which is itself a validated drug discovery and disease biomarker target due to its enzymatic function in chromatin biology and cancer[2][1][4]. ASH1L-IT1 is not considered a standard therapeutic target or part of any known drug-interaction pathways, and information is notably sparse and ambiguous in both the literature and databases. If you instead meant the canonical protein-coding ASH1L, clarify, as this is a well-characterized histone methyltransferase implicated in cancer, neurodevelopmental disorders, and other major roles[2][1][4][5][6][7].

Other names
lncRNA ASH1L-IT1ASH1L intronic transcript 1
02

Biological functions

Potential chromatin modulation or gene regulation; little validated information available
03

Disease associations

Possible correlations with cancer and epigenetic regulation, but role is unclear and not therapeutically targeted

Beyond the preview

Go deeper on ASH1L intronic transcript 1 (ASH1L-IT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ASH1L intronic transcript 1 (ASH1L-IT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call